Prevalence of liver fibrosis by Fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis.
Prashant BafnaRasmi Ranjan SahooKasturi HazarikaManesh ManojSumit RungtaAnupam WakhluPublished in: Clinical rheumatology (2021)
Long-term MTX therapy in RA was associated with increased liver stiffness on Fibroscan. Key Points • Fibroscan is a useful tool for monitoring MTX-induced liver fibrosis. • Liver fibrosis as evidenced by increased liver stiffness on Fibroscan is prevalent among patients on long-term MTX therapy for RA.
Keyphrases
- liver fibrosis
- rheumatoid arthritis
- disease activity
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- ankylosing spondylitis
- prognostic factors
- interstitial lung disease
- risk factors
- high dose
- high glucose
- stem cells
- diabetic rats
- oxidative stress
- systemic lupus erythematosus
- endothelial cells
- cell therapy